{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-secretions/how-this-topic-was-developed/evidence-exclusion-criteria/","result":{"pageContext":{"chapter":{"id":"42fc232e-bba3-513f-a5d9-15378200e570","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria","depth":2,"htmlHeader":"<!-- begin field 34dfc8f8-eb20-409c-94aa-a7f20188e665 --><h2>Evidence exclusion criteria</h2><!-- end field 34dfc8f8-eb20-409c-94aa-a7f20188e665 -->","summary":null,"htmlStringContent":"<!-- begin item d2e631ee-8a0b-41fa-921c-a7f20187a3cf --><!-- begin field de2d6e97-f651-4d51-8f4c-a7f20188e665 --><h2>Our policy</h2><!-- end field de2d6e97-f651-4d51-8f4c-a7f20188e665 --><!-- begin field d3288b49-bccb-462d-95b3-a7f20188e665 --><p>Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.</p><p>Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.</p><!-- end field d3288b49-bccb-462d-95b3-a7f20188e665 --><!-- begin field 4913d814-31cb-406f-8d51-a7f20188e665 --><h2>Standard exclusions for scoping literature:</h2><!-- end field 4913d814-31cb-406f-8d51-a7f20188e665 --><!-- begin field 66c671fc-6b1e-4d3a-9b70-a7f20188e665 --><ul><li>Animal studies</li><li>Original research is not written in English</li></ul><!-- end field 66c671fc-6b1e-4d3a-9b70-a7f20188e665 --><!-- begin field 4f30c65a-9e3d-4cdf-b9d3-a7f20188e665 --><h2>Possible exclusions for reviewed literature:</h2><!-- end field 4f30c65a-9e3d-4cdf-b9d3-a7f20188e665 --><!-- begin field 992896c4-6b0a-4315-9b4f-a7f20188e665 --><ul><li>Sample size too small or study underpowered</li><li>Bias evident or promotional literature</li><li>Population not relevant</li><li>Intervention/treatment not relevant</li><li>Outcomes not relevant</li><li>Outcomes have no clear evidence of clinical effectiveness</li><li>Setting not relevant</li><li>Not relevant to UK</li><li>Incorrect study type</li><li>Review article</li><li>Duplicate reference</li></ul><!-- end field 992896c4-6b0a-4315-9b4f-a7f20188e665 --><!-- end item d2e631ee-8a0b-41fa-921c-a7f20187a3cf -->","topic":{"id":"77f1b9af-1e60-5bb5-ae89-daa331210abe","topicId":"446cb057-c3b6-49c3-942c-3d8a40d02345","topicName":"Palliative care - secretions","slug":"palliative-care-secretions","lastRevised":"Last revised in October 2016","chapters":[{"id":"19f54d42-0888-50d9-a22b-cd4c095d346e","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"72433d6d-9301-5ca8-b910-6a552d6fce9c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"025bff54-f52a-54fb-b384-42f6b7abfb71","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"09dcf8ce-9483-5303-b1b2-68579072438f","slug":"changes","fullItemName":"Changes"},{"id":"fffc9f9e-45d1-50c5-be5f-b864988702ac","slug":"update","fullItemName":"Update"}]},{"id":"f0f7d1a1-4f58-53b4-a82a-1cee73e34be5","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5cf603f8-c6db-5f9a-8053-8078d5ca7704","slug":"goals","fullItemName":"Goals"},{"id":"d5a9411c-4efe-55f8-a100-b669fa635333","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6a870297-6340-5e00-91f5-76791ba8bc25","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"acfb93e5-0ab7-5b5e-abea-421e101ee036","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"76d1d9b7-098a-51c5-a8c8-ed432c562045","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"82517897-fd42-5e8b-9c87-986916cd1a05","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d4296b2d-b51d-58ce-8564-c1f97f3e17d1","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"7f6c0c77-0b74-5509-99a0-d46ccbb5df6a","slug":"definition","fullItemName":"Definition"},{"id":"a280c209-3fa8-5a6e-8cf1-77ecdb0c548f","slug":"why-do-secretions-accumulate","fullItemName":"Why do secretions accumulate"},{"id":"fcc81d76-7a24-5377-9a9c-871e7849434d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"6b5cc8f0-3cab-5d14-900a-459f40793235","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"aeac360c-7bd9-5b2d-a7f0-979347e4a423","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b6e50011-ccf0-5fd1-b5ba-a11dab328604","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"6f40bc41-9977-54ec-b25f-77e34d1c3cac","fullItemName":"Management","slug":"management","subChapters":[{"id":"1365445e-f6e4-583d-84ac-dfa2d7ec2981","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"f01d488f-b942-5c1f-839b-84f60cb644a3","slug":"noisy-respiratory-secretions-at-the-end-of-life","fullItemName":"Scenario: Noisy respiratory secretions at the end of life"}]},{"id":"8d463ab9-510c-50ff-b9e2-2a5202e4693e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"24d654c1-72b5-5691-b5ab-2b633207259e","slug":"which-antimuscarinic-to-prescribe","fullItemName":"Which antimuscarinic to prescribe"},{"id":"1819f9d9-cb20-5283-9237-36370d8eaf04","slug":"dose-of-antimuscarinic","fullItemName":"Dose of antimuscarinic"},{"id":"0e997e9e-35ef-5150-9b22-44631bbe9875","slug":"adverse-effects-of-antimuscarinics","fullItemName":"Adverse effects of antimuscarinics"},{"id":"c4ecff94-72a7-5298-9eff-aa0f014bd0d2","slug":"administering-drugs-via-syringe-driver","fullItemName":"Administering drugs via syringe driver"}]},{"id":"fc7ec3a1-6164-5fce-ae68-ea76a7e7ed95","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[{"id":"f0bd35d1-28aa-5304-bbae-6437a5cff4f8","slug":"antimuscarinics-for-respiratory-secretions","fullItemName":"Antimuscarinics for respiratory secretions"}]},{"id":"13aa02e3-ed7e-5603-b3cf-c8c77f16c1ad","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9720e3b4-46d0-5fc7-a0db-be67e6db6bfa","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"92414bd0-2c9f-584a-badf-10b45f202fc3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"42fc232e-bba3-513f-a5d9-15378200e570","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"68c17f61-0db1-544c-a0b5-b14bb9ce5c5c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"bf6037b2-67c3-5d11-ae91-c606813ad76d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"741bbef8-7d2e-53e4-ae09-0cb22ef8d617","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"13aa02e3-ed7e-5603-b3cf-c8c77f16c1ad","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}